Bioequivalence evaluation of Azithromycin Capsule 500 mg of Mahban Pharmaceutical company
Not Applicable
- Conditions
- --.
- Registration Number
- IRCT20200625047913N15
- Lead Sponsor
- Hezareh Sevom Futuristic Pharmacist
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
18 to 45 years old
Sex: Males and/or females
BMI: 18.5 to 24.9 Kg/m2
Being able to communicate effectively with study personnel and willingness to follow the protocol requirements as evidenced by written informed consent
A physical examination with no clinically significant finding and laboratory normal tests
Exclusion Criteria
Chronic or acute use of any medication at least 1 week before the start of the study
History of diseases affecting the pharmacokinetic processes of the drug
Pregnancy
Lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method